Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05306418 · ClinicalTrials.gov registry record · Phase 3
A Research Study Looking at Mim8 in Children With Haemophilia A With or Without Inhibitors
A Phase 3 study, sponsored by Novo Nordisk A/S.
- Completed
- Registry status
- Phase 3
- Development phase
- 70
- Enrollment target
NCT05306418 is a Phase 3 study that has completed, run by Novo Nordisk A/S. The registered enrollment target is 70 participants.
The verdict
NCT05306418, a Phase 3 study, has completed, sponsored by Novo Nordisk A/S.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 70 participants
- Enrollment target
Study Summary
This study is looking at how Mim8 works compared to other medicines in children with haemophilia A, who either have inhibitors or do not have inhibitors. Mim8 is a new medicine that will be used for prevention of bleeds. Mim8 will be injected with a thin needle into the skin. The study will last for about 54-98 weeks, from screening to follow-up visit, In case the participant experiences bleeds, these can be treated with additional haemostatic medicine as agreed with the study doctor.
Interventions
- DRUG Mim8
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2022-04-04 |
| Est. Completion | 2024-11-13 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05306418
The ClinicalTrials.gov registry entry for NCT05306418 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novo Nordisk A/S, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mim8 is the first listed.
NCT05306418 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05306418 about?
NCT05306418 is a clinical study titled "A Research Study Looking at Mim8 in Children With Haemophilia A With or Without Inhibitors". This study is looking at how Mim8 works compared to other medicines in children with haemophilia A, who either have inhibitors or do not have inhibitors. Mim8 is a new medicine that will be used for prevention of bleeds. Mim8 will be injected with a thin needle into the skin. The study will last fo...
What is the current status of trial NCT05306418?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 70 participants. The study started on 2022-04-04. Estimated completion is 2024-11-13.
What interventions are being tested in trial NCT05306418?
The interventions under investigation include: Mim8 (DRUG).
Who is sponsoring clinical trial NCT05306418?
This trial is sponsored by Novo Nordisk A/S, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.